In 2021, the style of A-share market changes, the structural differentiation intensifies, and the investment difficulty increases significantly. In such a market environment, Zheshang fund took the “Hi + AI (Human-Computer Interaction)” intelligent investment system as the strategic guidance, improved the product layout and obtained a certain degree of market recognition from the perspective of improving the long-term holding experience of investors.
Haitong Securities Company Limited(600837) according to the latest data, the long-term performance (nearly seven years) and short-term performance (nearly three years) of equity assets of Zheshang fund are in the top 1 / 3 of the industry, and the performance of fixed income assets ranks in the top 10 of its kind in recent one year.
It is reported that at present, Zheshang fund has four types of “Ai +” portfolio products: AI strategy, hi + AI, AI + beta and AI + absolute return strategy:
The “Ai strategy” products represented by Zheshang intelligent industry preferred a have increased by 102.76% since its establishment, with significant excess return. This system is managed by Xiang Weizai, deputy general manager of intelligent equity investment department and AI principal. Dr. Xiang Wei has 16 years of AI research and practical experience and is the promoter of quantitative fundamental research and intelligent investment in China.
Hi + AI strategy system, relying on the advantages of AI strategy, helps fund managers release from heavy data research and focus on excess returns. The high alpha products represented by Zheshang’s rolling holding of a in one month of scientific and technological innovation increased by 41.37% in the recent year, and the revenue significantly outperformed the benchmark. Zheshang fund has a group of experienced Mesozoic fund managers, such as Chen Penghui, Wang Bin, Bai Yu, Chai Ming, etc. the average industry research experience is nearly 10 years, and the research fields can cover new energy, military industry, medicine, 5g, photovoltaic and other fields, representing China’s Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) future.
Under the layout of AI + beta, the standard industrial products represented by Zhejiang Merchants China Securities 500 index enhancement a have certain market competitiveness under the joint management of Dr. Xiang Wei and fund manager Hu Yi, with an increase of 27.85% in the last year and ranking No. 5 in the same category in the past two years.
For the absolute return strategy products represented by “Zhiduo” series, the source of income is divided into fixed income and equity, with bond bottoming and equity enhancement. Ouyang Jian, a veteran with 20 years of working experience, led the fixed income team to achieve medium and long-term benefits.
